BioNexus Gene Lab
BGLC
trading on NASDAQ
since 2020
$6.25
(Δ 43.76%)
+$1.86 since open
BioNexus Gene Lab specializes in pioneering advanced gene-editing technologies, including CRISPR-based tools, to develop innovative solutions for precision medicine and agricultural advancements.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $4.92 | $7.05 | $4.51 | $10.46M | 6.45M |
| eps | p/e | p/s |
operating margin |
profit margin |
yield |
| +$0.00 | n/a | 52.55 | -28.94% | -29.17% | 0% |